Dan-Dan Li Selected Research

Melanoma (Melanoma, Malignant)

5/2022	Efficacy and safety of anti-PD-1 inhibitor combined with nab-paclitaxel in Chinese patients with refractory melanoma.
1/2022	HHLA2 predicts improved prognosis of anti-PD-1/PD-L1 immunotherapy in patients with melanoma.
1/2021	Safety and Tolerability of BRAF Inhibitor and BRAF Inhibitor-Based Combination Therapy in Chinese Patients With Advanced Melanoma: A Real World Study.
1/2020	Association between immune-related adverse events and efficacy of PD-1 inhibitors in Chinese patients with advanced melanoma.
1/2019	Down Regulation of c-FLIPL Enhance PD-1 Blockade Efficacy in B16 Melanoma.
10/2017	A prognostic model for resectable acral melanoma patients on the basis of preoperative inflammatory markers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dan-Dan Li Research Topics

Disease

36	Neoplasms (Cancer) 10/2023 - 11/2008
9	Hepatocellular Carcinoma (Hepatoma) 02/2023 - 07/2010
8	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 10/2009
6	Inflammation (Inflammations) 01/2024 - 01/2016
6	Melanoma (Melanoma, Malignant) 05/2022 - 10/2017
5	Hypertension (High Blood Pressure) 01/2023 - 11/2012
5	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2012
4	Neoplasm Metastasis (Metastasis) 10/2023 - 06/2016
4	Hyperlipidemias (Hyperlipidemia) 08/2023 - 09/2014
4	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2009
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2019 - 01/2014
3	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 01/2017
3	Liver Neoplasms (Liver Cancer) 01/2018 - 11/2016
3	Carcinogenesis 01/2017 - 11/2008
3	Thyroid Nodule (Nodule, Thyroid) 01/2017 - 01/2016
3	Stroke (Strokes) 05/2016 - 10/2012
3	Fibrosis (Cirrhosis) 09/2014 - 07/2009
2	Rectal Neoplasms (Rectal Cancer) 01/2024 - 10/2022
2	Microsatellite Instability 01/2024 - 10/2022
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2023 - 01/2022
2	Acute Coronary Syndrome 04/2023 - 05/2016
2	Infertility (Sterility) 04/2023 - 01/2022
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 04/2021
2	Male Infertility (Male Sterility) 10/2022 - 04/2015
2	Insulin Resistance 01/2022 - 05/2018
2	Neuroblastoma 07/2021 - 10/2017
2	Starvation 05/2021 - 08/2011
2	Neuroinflammatory Diseases 01/2020 - 01/2018
2	Hyperglycemia 01/2019 - 03/2012
2	Carcinoma (Carcinomatosis) 01/2018 - 01/2015
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2015 - 04/2014
2	Nausea 01/2014 - 10/2013
2	Squamous Cell Carcinoma of Head and Neck 01/2014 - 10/2009
2	Vomiting 01/2014 - 10/2013
2	Coronary Disease (Coronary Heart Disease) 11/2012 - 11/2012
2	Lung Neoplasms (Lung Cancer) 10/2011 - 10/2009
2	Silicosis 10/2010 - 07/2009
1	Arthritis (Polyarthritis) 01/2024
1	Arthralgia (Joint Pain) 01/2024
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2024
1	Adenoma (Adenomas) 10/2023
1	Colonic Polyps 10/2023
1	Polyps 10/2023
1	Turcot syndrome 10/2023

Drug/Important Bio-Agent (IBA)

7	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 03/2012
6	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2019
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2011
6	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2018 - 07/2010
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2009
5	MicroRNAs (MicroRNA)IBA 01/2018 - 02/2013
3	LipidsIBA 08/2023 - 01/2022
3	AntioxidantsIBA 01/2023 - 06/2016
3	SodiumIBA 01/2023 - 07/2009
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2022 - 05/2018
3	Beclin-1IBA 12/2021 - 11/2008
3	CytokinesIBA 01/2020 - 01/2016
3	Cisplatin (Platino)FDA LinkGeneric 05/2019 - 01/2014
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2018 - 06/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2012
3	Topotecan (Hycamtin)FDA LinkGeneric 06/2016 - 10/2011
3	hirsutanol AIBA 02/2013 - 07/2010
2	IntegrinsIBA 02/2023 - 01/2017
2	Programmed Cell Death 1 ReceptorIBA 10/2022 - 01/2019
2	LigandsIBA 03/2022 - 01/2022
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 04/2009
2	CholesterolIBA 11/2020 - 06/2013
2	Transcription Factors (Transcription Factor)IBA 06/2020 - 01/2017
2	zileuton (Zyflo)FDA Link 01/2020 - 01/2018
2	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2020 - 01/2018
2	LipopolysaccharidesIBA 01/2020 - 01/2018
2	UbiquitinIBA 01/2020 - 01/2017
2	Epirubicin (Ellence)FDA LinkGeneric 02/2019 - 10/2017
2	Caspase 3 (Caspase-3)IBA 01/2019 - 04/2009
2	CopperIBA 10/2018 - 01/2017
2	Messenger RNA (mRNA)IBA 05/2018 - 07/2009
2	LuciferasesIBA 07/2017 - 02/2015
2	2-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA 01/2017 - 01/2017
2	Sirtuin 1IBA 02/2015 - 03/2012
2	Phosphotransferases (Kinase)IBA 01/2015 - 04/2009
2	Transforming Growth Factor beta (TGF-beta)IBA 09/2014 - 07/2009
2	CaspasesIBA 08/2014 - 08/2010
2	Hemoglobins (Hemoglobin)IBA 01/2014 - 06/2013
2	Triglycerides (Triacylglycerol)IBA 06/2013 - 11/2012
2	SesquiterpenesIBA 02/2013 - 07/2010
2	SuspensionsIBA 10/2010 - 07/2009
2	goralatideIBA 10/2010 - 07/2009
2	Silicon Dioxide (Silica)FDA LinkGeneric 10/2010 - 07/2009
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2024
1	Calcibiotic Root Canal SealerIBA 10/2023
1	antiarrhythmic peptide (AAP)IBA 08/2023
1	Fenofibrate (CiL)FDA LinkGeneric 08/2023
1	Polysaccharides (Glycans)IBA 08/2023

Therapy/Procedure

13	Therapeutics 01/2024 - 10/2012
8	Drug Therapy (Chemotherapy) 01/2023 - 10/2011
7	Immunotherapy 01/2024 - 01/2018
4	Aftercare (After-Treatment) 10/2023 - 08/2010
3	Radiofrequency Ablation 10/2017 - 01/2016
2	Radiotherapy 01/2023 - 01/2016
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 04/2009
1	Neoadjuvant Therapy 10/2023